Bid
Ask
/product/detail/index/isin/CH0460006445
46000644AAATFU
Swisscom13.35%0.65% p.a.05.08.2020CHF460.25462.00
/product/detail/index/isin/CH0461589563
46158956AAAABU
Novartis Basket12.46%--14.02.2020CHF89.7090.15
/product/detail/index/isin/CH0465318530
46531853MONDAU
Anglo American14.15%5.82% p.a.03.03.2020GBP18.1818.38
/product/detail/index/isin/CH0470250074
47025007AKUUUU
Biogen20.59%9.01% p.a.08.04.2020USD224.62225.69
/product/detail/index/isin/CH0472609400
47260940BMYNNU
Bristol-Myers Squibb33.00%1.89% p.a.17.04.2020USD44.5744.80
/product/detail/index/isin/CH0472618336
47261833AMGNUU
Amgen26.06%2.68% p.a.24.04.2020USD172.89173.80
/product/detail/index/isin/CH0472618450
47261845SEGOVU
Bristol-Myers Squibb36.74%1.83% p.a.24.04.2020USD42.0742.30
/product/detail/index/isin/CH0475019714
47501971BLCUUU
Swiss Re18.62%1.52% p.a.09.11.2020CHF90.0590.50
/product/detail/index/isin/CH0475030349
47503034GOLDSU
Barrick Gold24.80%3.33% p.a.13.05.2020USD13.8013.86
/product/detail/index/isin/CH0479745306
47974530ALEJAU
Gilead3.69%10.54% p.a.05.06.2020USD61.2661.58
/product/detail/index/isin/CH0482618631
48261863BLASCU
Biogen23.51%8.68% p.a.19.06.2020USD214.98217.38
/product/detail/index/isin/CH0482624696
48262469BMYBLU
Bristol-Myers Squibb27.52%2.63% p.a.23.06.2020USD48.2448.47
/product/detail/index/isin/CH0482624704
48262470GILBLU
Gilead3.88%9.90% p.a.23.06.2020USD61.1261.46
/product/detail/index/isin/CH0485096355
48509635FARISU
Barrick Gold9.39%17.35% p.a.09.07.2020USD16.6216.70
/product/detail/index/isin/CH0487348432
48734843BLGOLU
Barrick Gold8.68%18.53% p.a.04.08.2020USD16.7416.83
/product/detail/index/isin/CH0487349380
48734938 
Gilead7.16%14.37% p.a.06.08.2020USD59.0359.36
/product/detail/index/isin/CH0490248413
49024841BLBIOU
Biogen22.90%10.68% p.a.14.07.2020USD217.98219.14
/product/detail/index/isin/CH0490250302
49025030BLOAMU
Amgen24.56%3.12% p.a.17.07.2020USD176.43177.31
/product/detail/index/isin/CH0490256010
49025601BLIBMU
IBM7.22%16.23% p.a.22.07.2020USD131.80132.55
/product/detail/index/isin/CH0492621906
49262190BCINDU
Bristol-Myers Squibb26.14%3.51% p.a.11.09.2020USD49.1549.39
  • 10 per page
  • 20 per page
  • 50 per page
  • 100 per page

Discount certificate (UBS BLOC)

A UBS BLOC (Buy Low Or Cash), also known as a discount certificate, enables investors with a moderate-to-high risk tolerance to obtain a price reduction when purchasing a selected underlying asset (e.g. index, equity, currency pair or precious metal). The more favorable entry results in a return benefit so that attractive returns are possible even in a sideways moving market.

Participating in price increases is limited: as soon as the price of the underlying asset trades at or above the cap level at maturity, the UBS BLOC will yield the anticipated return. The price reduction granted at the beginning results in investors benefiting from a safety buffer. Buyers of a UBS BLOC are almost always in a better position when the prices of the underlying asset fall than direct investors are, as they usually suffer fewer losses in terms of percentage.

However, the reduction in price is not full protection at maturity. If the underlying asset trades below the purchase price paid for the certificate there will be a loss in the capital invested. If the underlying asset closes below the cap level at maturity, the repayment is linked directly to the price of the underlying asset. The investor is then either paid the value of the underlying asset or the cash value of the underlying asset adjusted by the subscription ratio. In addition, the issuer risk must be taken into consideration, since the invested capital could be lost if UBS AG becomes insolvent, irrespective of the performance of the underlying asset.

A more detailed product description is available in our brochure "Knowledge in a nutshell".